- Home
- BCPC vs ACT Comparison
BCPC vs ACT Comparison
Compare BCPC & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCPC | ACT |
|---|---|---|
| Founded | 1967 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Specialty Insurers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.8B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BCPC | ACT |
|---|---|---|
| Price | $166.63 | $40.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $176.00 | $42.67 |
| AVG Volume (30 Days) | 137.2K | ★ 261.1K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | 0.58% | ★ 2.06% |
| EPS Growth | ★ 20.87 | 3.43 |
| EPS | ★ 4.75 | 4.52 |
| Revenue | $799,023,000.00 | ★ $1,235,827,000.00 |
| Revenue This Year | $8.47 | $4.22 |
| Revenue Next Year | $4.89 | $2.33 |
| P/E Ratio | $35.04 | ★ $9.02 |
| Revenue Growth | ★ 13.56 | 2.83 |
| 52 Week Low | $139.17 | $31.28 |
| 52 Week High | $183.90 | $44.80 |
Technical Indicators
Market Signals| Indicator | BCPC | ACT |
|---|---|---|
| Relative Strength Index (RSI) | 43.30 | 42.47 |
| Support Level | $165.89 | $39.31 |
| Resistance Level | $171.32 | $41.12 |
| Average True Range (ATR) | 4.02 | 0.81 |
| MACD | -0.41 | -0.06 |
| Stochastic Oscillator | 44.14 | 17.22 |
Price Performance
Historical ComparisonAbout BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.